Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 5Rectal Neoplasms 3Esophageal Squamous Cell Carcinoma 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Waldenstrom Macroglobulinemia 1Triple Negative Breast Neoplasms 1Stress, Psychological 1Stomach Neoplasms 1Stage III and IV Ovarian Cancer 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Pathologic Complete Response 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplasm, Residual 1Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer 1NSCLC 1Muscle-Invasive Bladder Carcinoma 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Locally Advanced Cervical Cancer 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Carcinoma, Ovarian Epithelial 1Bites and Stings 1Anxiety Disorders 1

Interventions

Neoadjuvant Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Muscle-Invasive Bladder Carcinoma × Neoadjuvant Therapy × Clear all
NCT06325423 2024-03-26

Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

Assiut University

Not yet recruiting
50 enrolled

Muscle-Invasive Bladder Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡